{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:57:32Z","timestamp":1765886252635},"reference-count":48,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2020]]},"DOI":"10.1620\/tjem.251.183","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:06:10Z","timestamp":1594677970000},"page":"183-191","source":"Crossref","is-referenced-by-count":5,"title":["Serum Alanine Transaminase as a Predictor of Type 2 Diabetes Incidence: The Yuport Prospective Cohort Study"],"prefix":"10.1620","volume":"251","author":[{"given":"Yu","family":"Hatano","sequence":"first","affiliation":[{"name":"Department of Family Medicine and Community Health, Duke University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Chiba Medical Center, Teikyo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Kashima","sequence":"additional","affiliation":[{"name":"Environmental Health Sciences Laboratory, Graduate School of Advanced Science and Engineering, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Community-Based Medical System, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimihiko","family":"Akimoto","sequence":"additional","affiliation":[{"name":"Akimoto Occupational Health Consultant Office"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","unstructured":"American Diabetes Association (2017)  2.  Classification and diagnosis of diabetes.  <i>Diabetes Care<\/i>, 40, S11-S24."},{"key":"2","unstructured":"Austin, P.C. (2011)  An introduction to propensity score methods for reducing the effects of confounding in observational studies.  <i>Multivariate Behav. Res.<\/i>, 46, 399-424."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Bonnet, F., Ducluzeau, P.H., Gastaldelli, A., Laville, M., Anderwald, C.H., Konrad, T., Mari, A. &amp; Balkau, B.; the RISC Study Group (2011)  Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women.  <i>Diabetes<\/i>, 60, 1660-1667.","DOI":"10.2337\/db10-1806"},{"key":"4","unstructured":"Brandish, E. &amp; Sheron, N. (2010)  Drinking patterns and the risk of serious liver disease.  <i>Expert Rev. Gastroenterol. Hepatol.<\/i>, 4, 249-252."},{"key":"5","unstructured":"Cales, P., Laine, F., Boursier, J., Deugnier, Y., Moal, V., Oberti, F., Hunault, G., Rousselet, M.C., Hubert, I., Laafi, J., Ducluzeaux, P.H. &amp; Lunel, F. (2009)  Comparison of blood tests for liver fibrosis specific or not to NAFLD.  <i>J. Hepatol.<\/i>, 50, 165-173."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cepeda, M.S., Boston, R., Farrar, J.T. &amp; Strom, B.L. (2003)  Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders.  <i>Am. J. Epidemiol.<\/i>, 158, 280-287.","DOI":"10.1093\/aje\/kwg115"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Chang, Y., Jung, H.S., Yun, K.E., Cho, J., Cho, Y.K. &amp; Ryu, S. (2013)  Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.  <i>Am. J. Gastroenterol.<\/i>, 108, 1861-1868.","DOI":"10.1038\/ajg.2013.349"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Cho, N.H., Jang, H.C., Choi, S.H., Kim, H.R., Lee, H.K., Chan, J.C. &amp; Lim, S. (2007)  Abnormal liver function test predicts type 2 diabetes: a community-based prospective study.  <i>Diabetes Care<\/i>, 30, 2566-2568.","DOI":"10.2337\/dc07-0106"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus; Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., Kasuga, M., Hanafusa, T., Haneda, M. &amp; Ueki, K. (2010)  Report of the committee on the classification and diagnostic criteria of diabetes mellitus.  <i>J. Diabetes Investig.<\/i>, 1, 212-228.","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"De Silva, N.M.G., Borges, M.C., Hingorani, A.D., Engmann, J., Shah, T., Zhang, X., Luan, J., Langenberg, C., Wong, A., Kuh, D., Chambers, J.C., Zhang, W., Jarvelin, M.R., Sebert, S., Auvinen, J., et al. (2019)  Liver function and risk of type 2 diabetes: bidirectional Mendelian randomization study.  <i>Diabetes<\/i>, 68, 1681-1691.","DOI":"10.2337\/db18-1048"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Ding, P. &amp; VanderWeele, T.J. (2016)  Sensitivity analysis without assumptions.  <i>Epidemiology<\/i>, 27, 368-377.","DOI":"10.1097\/EDE.0000000000000457"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Doi, Y., Kubo, M., Yonemoto, K., Ninomiya, T., Iwase, M., Tanizaki, Y., Shikata, K., Iida, M. &amp; Kiyohara, Y. (2007)  Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study.  <i>Obesity<\/i> (<i>Silver Spring<\/i>), 15, 1841-1850.","DOI":"10.1038\/oby.2007.218"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Dowman, J.K., Tomlinson, J.W. &amp; Newsome, P.N. (2010)  Pathogenesis of non-alcoholic fatty liver disease.  <i>QJM<\/i>, 103, 71-83.","DOI":"10.1093\/qjmed\/hcp158"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ford, E.S., Schulze, M.B., Bergmann, M.M., Thamer, C., Joost, H.G. &amp; Boeing, H. (2008)  Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.  <i>Diabetes Care<\/i>, 31, 1138-1143.","DOI":"10.2337\/dc07-2159"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G. &amp; Lawlor, D.A. (2009)  Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women\u2019s Heart and Health Study and meta-analysis.  <i>Diabetes Care<\/i>, 32, 741-750.","DOI":"10.2337\/dc08-1870"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Friedman, S.L. (2003)  Liver fibrosis : from bench to bedside.  <i>J. Hepatol.<\/i>, 38 Suppl 1, S38-53.","DOI":"10.1016\/S0168-8278(02)00429-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Fujita, M., Ueno, K. &amp; Hata, A. (2010)  Association of gamma-glutamyltransferase with incidence of type 2 diabetes in Japan.  <i>Exp. Biol. Med.<\/i> (<i>Maywood<\/i>), 235, 335-341.","DOI":"10.1258\/ebm.2009.009232"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Goessling, W., Massaro, J.M., Vasan, R.S., D\u2019Agostino, R.B. Sr., Ellison, R.C. &amp; Fox, C.S. (2008)  Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.  <i>Gastroenterology<\/i>, 135, 1935-1944.  e1.","DOI":"10.1053\/j.gastro.2008.09.018"},{"key":"19","unstructured":"Guariguata, L., Whiting, D.R., Hambleton, I., Beagley, J., Linnenkamp, U. &amp; Shaw, J.E. (2014)  Global estimates of diabetes prevalence for 2013 and projections for 2035.  <i>Diabetes Res. Clin. Pract.<\/i>, 103, 137-149."},{"key":"20","doi-asserted-by":"crossref","unstructured":"He, X., Rebholz, C.M., Daya, N., Lazo, M. &amp; Selvin, E. (2019)  Alcohol consumption and incident diabetes: the Atherosclerosis Risk in Communities (ARIC)  study.  <i>Diabetologia<\/i>, 62, 770-778.","DOI":"10.1007\/s00125-019-4833-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Hoelzel, W., Weykamp, C., Jeppsson, J.O., Miedema, K., Barr, J.R., Goodall, I., Hoshino, T., John, W.G., Kobold, U., Little, R., Mosca, A., Mauri, P., Paroni, R., Susanto, F., Takei, I., et al. (2004)  IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.  <i>Clin. Chem.<\/i>, 50, 166-174.","DOI":"10.1373\/clinchem.2003.024802"},{"key":"22","unstructured":"Hozawa, A., Okamura, T., Tanaka, T., Miura, K., Kikuchi, Y., Kadowaki, T., Yoshita, K., Takebayashi, T., Tamaki, J., Minai, J., Tada, T., Chiba, N., Okayama, A. &amp; Ueshima, H. (2010)  Relation of Gamma-glutamyltransferase and alcohol drinking with incident diabetes: the HIPOP-OHP study.  <i>J. Atheroscler. Thromb.<\/i>, 17, 195-202."},{"key":"23","unstructured":"IDF Diabetes Atlas Group (2013)  Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2011.  <i>Diabetes Res. Clin. Pract.<\/i>, 100, 277-279."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Inoue, K., Inoue, M., Matsumoto, M. &amp; Akimoto, K. (2012)  Persistent fasting hyperglycaemia is more predictive of type 2 diabetes than transient fasting hyperglycaemia.  <i>Diabet. Med.<\/i>, 29, e75-81.","DOI":"10.1111\/j.1464-5491.2011.03536.x"},{"key":"25","unstructured":"Inoue, K., Matsumoto, M. &amp; Akimoto, K. (2009)  The threshold for definition of impaired fasting glucose in a Japanese population.  <i>Diabet. Med.<\/i>, 26, 1175-1178."},{"key":"26","doi-asserted-by":"crossref","unstructured":"Kaneko, K., Yatsuya, H., Li, Y., Uemura, M., Chiang, C., Hirakawa, Y., Ota, A., Tamakoshi, K. &amp; Aoyama, A. (2019)  Association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow up.  <i>J. Diabetes Investig.<\/i>, 10, 837-845.","DOI":"10.1111\/jdi.12930"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Kashiwagi, A., Kasuga, M., Araki, E., Oka, Y., Hanafusa, T., Ito, H., Tominaga, M., Oikawa, S., Noda, M., Kawamura, T., Sanke, T., Namba, M., Hashiramoto, M., Sasahara, T., Nishio, Y., et al. (2012)  International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values.  <i>J. Diabetes Investig.<\/i>, 3, 39-40.","DOI":"10.1007\/s13340-012-0069-8"},{"key":"28","unstructured":"Kawaguchi, T., Taniguchi, E., Itou, M., Sakata, M., Sumie, S. &amp; Sata, M. (2011)  Insulin resistance and chronic liver disease.  <i>World J. Hepatol.<\/i>, 3, 99-107."},{"key":"29","unstructured":"Kim, C.H., Park, J.Y., Lee, K.U., Kim, J.H. &amp; Kim, H.K. (2009)  Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.  <i>Diabetes Metab. Res. Rev.<\/i>, 25, 64-69."},{"key":"30","unstructured":"Kuzuya, T., Nakagawa, S., Satoh, J., Kanazawa, Y., Iwamoto, Y., Kobayashi, M., Nanjo, K., Sasaki, A., Seino, Y., Ito, C., Shima, K., Nonaka, K. &amp; Kadowaki, T.;  Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus (2002)  Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.  <i>Diabetes Res. Clin. Pract.<\/i>, 55, 65-85."},{"key":"31","unstructured":"Kwo, P.Y., Cohen, S.M. &amp; Lim, J.K. (2017)  ACG Clinical Guideline: evaluation of abnormal liver chemistries.  <i>Am. J. Gastroenterol.<\/i>, 112, 18-35."},{"key":"32","unstructured":"Li, Y., Wang, J., Han, X., Hu, H., Wang, F., Yu, C., Yuan, J., Yao, P., Li, X., Yang, K., Miao, X., Wei, S., Wang, Y., Chen, W., Liang, Y., et al. (2019)  Serum alanine transaminase levels predict type 2 diabetes risk among a middle-aged and elderly Chinese population.  <i>Ann. Hepatol.<\/i>, 18, 298-303."},{"key":"33","doi-asserted-by":"crossref","unstructured":"Liu, J., Au Yeung, S.L., Lin, S.L., Leung, G.M. &amp; Schooling, C.M. (2016)  Liver enzymes and risk of ischemic heart disease and type 2 diabetes mellitus: a Mendelian randomization study.  <i>Sci. Rep.<\/i>, 6, 38813.","DOI":"10.1038\/srep38813"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Nakanishi, N., Nishina, K., Li, W., Sato, M., Suzuki, K. &amp; Tatara, K. (2003a)  Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.  <i>J. Intern. Med.<\/i>, 254, 287-295.","DOI":"10.1046\/j.1365-2796.2003.01198.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Nakanishi, N., Suzuki, K. &amp; Tatara, K. (2003b)  Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.  <i>Diabetes Care<\/i>, 26, 48-54.","DOI":"10.2337\/diacare.26.1.48"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Nakanishi, N., Suzuki, K. &amp; Tatara, K. (2004)  Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.  <i>Diabetes Care<\/i>, 27, 1427-1432.","DOI":"10.2337\/diacare.27.6.1427"},{"key":"37","unstructured":"Okamoto, M., Takeda, Y., Yoda, Y., Kobayashi, K., Fujino, M.A. &amp; Yamagata, Z. (2003)  The association of fatty liver and diabetes risk.  <i>J. Epidemiol.<\/i>, 13, 15-21."},{"key":"38","unstructured":"Qatanani, M. &amp; Lazar, M.A. (2007)  Mechanisms of obesity-associated insulin resistance: many choices on the menu.  <i>Genes Dev.<\/i>, 21, 1443-1455."},{"key":"39","doi-asserted-by":"crossref","unstructured":"Robins, J.M., Hernan, M.A. &amp; Brumback, B. (2000)  Marginal structural models and causal inference in epidemiology.  <i>Epidemiology<\/i>, 11, 550-560.","DOI":"10.1097\/00001648-200009000-00011"},{"key":"40","unstructured":"Shah, A.G., Lydecker, A., Murray, K., Tetri, B.N., Contos, M.J. &amp; Sanyal, A.J.; Nash Clinical Research Network (2009)  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.  <i>Clin. Gastroenterol. Hepatol.<\/i>, 7, 1104-1112."},{"key":"41","doi-asserted-by":"crossref","unstructured":"Vallet-Pichard, A., Mallet, V., Nalpas, B., Verkarre, V., Nalpas, A., Dhalluin-Venier, V., Fontaine, H. &amp; Pol, S. (2007)  FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection.  comparison with liver biopsy and fibrotest.  <i>Hepatology<\/i>, 46, 32-36.","DOI":"10.1002\/hep.21669"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Wai, C.T., Greenson, J.K., Fontana, R.J., Kalbfleisch, J.D., Marrero, J.A., Conjeevaram, H.S. &amp; Lok, A.S. (2003)  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.  <i>Hepatology<\/i>, 38, 518-526.","DOI":"10.1053\/jhep.2003.50346"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Waki, K., Noda, M., Sasaki, S., Matsumura, Y., Takahashi, Y., Isogawa, A., Ohashi, Y., Kadowaki, T. &amp; Tsugane, S.; JPHC Study Group (2005)  Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I.  <i>Diabet. Med.<\/i>, 22, 323-331.","DOI":"10.1111\/j.1464-5491.2004.01403.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Williamson, T. &amp; Ravani, P. (2017)  Marginal structural models in clinical research: when and how to use them?  <i>Nephrol. Dial. Transplant.<\/i>, 32, ii84-ii90.","DOI":"10.1093\/ndt\/gfw341"},{"key":"45","unstructured":"World Health Organization (2016)  Global Report on Diabetes.  http:\/\/apps.who.int\/iris\/bitstream\/10665\/204871\/1\/9789241565257_eng.pdf [<i>Accessed<\/i>: October 10, 2019]."},{"key":"46","doi-asserted-by":"crossref","unstructured":"Xu, L., Jiang, C.Q., Schooling, C.M., Zhang, W.S., Cheng, K.K. &amp; Lam, T.H. (2015)  Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.  <i>J. Epidemiol. Community Health<\/i>, 69, 1040-1044.","DOI":"10.1136\/jech-2015-205518"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Xu, S., Ross, C., Raebel, M.A., Shetterly, S., Blanchette, C. &amp; Smith, D. (2010)  Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.  <i>Value Health<\/i>, 13, 273-277.","DOI":"10.1111\/j.1524-4733.2009.00671.x"},{"key":"48","unstructured":"Zhang, J., Cheng, N., Ma, Y., Li, H., Cheng, Z., Yang, Y., He, C., Li, J., Pu, H., Shen, X., Ren, X., Shi, D., Pu, R., Gan, T., Ding, J., et al. (2018)  Liver enzymes, fatty liver and type 2 diabetes mellitus in a Jinchang Cohort: a prospective study in adults.  <i>Can. J. Diabetes<\/i>, 42, 652-658."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/251\/3\/251_183\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T03:38:51Z","timestamp":1595043531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/251\/3\/251_183\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.251.183","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}